title: Reply to defining the role of radiofrequency ablation and stereotactic ablative radiotherapy in patients with high-risk, early-stage non-small cell lung cancer.
authors.affiliation: Department of Thoracic Surgery, Boston University Medical Center, Boston, Massachusetts.
authors.forename: Hiran C
authors.initials: HC
authors.lastname: Fernando
authors.affiliation: Department of Diagnostic Imaging, Rhode Island Hospital, Providence, Rhode Island.
authors.forename: Damian E
authors.initials: DE
authors.lastname: Dupuy
mesh_terms: D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy*; D017115:Catheter Ablation / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D016634:Radiosurgery / Q000379:methods*